Archives for July 2007
HemCon Dental Dressing Receives CE Mark
HemCon Medical Technologies, of Portland, OR, has received clearance to sell its Dental Dressing in Europe, satisfying the international demand that’s been present since the product became available last year in the U.S. Armed with the CE Mark, the company will begin distributing dressings in the U.K., Germany and other EU countries.
The HemCon Dental Dressing […]
Chembio Teams Up with Pall Corporation
Chembio Diagnostics, of Medford, NY, has signed an R&D deal with Pall Corporation for use of Chembio’s new Dual Path Platform (DPP) immunoassay. The collaboration will involve a two-phase funded feasibility study to determine certain performance characteristics of DPP when used in conjunction with certain markers that are of interest to East Hills, NY-based Pall.
The […]
New Cerebral-Aneurysm Device Cleared in Europe
ev3, a Plymouth, MN-based endovascular device firm, has received CE Mark approval for a new product that treats cerebral aneurysm. The Axium Detachable Coil System was approved for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae.
Coiling procedures involve the delivery of platinum coils to the aneurysm […]
Breast-Cancer Detection Firm Seeks Series C Funding
Infrared Sciences, a Stony Brook, NY-based company focused on early breast-cancer detection, is seeking $5 million in fourth-round financing, to further advance its Sentinel BreastScan technology.
Unlike mammography, ultrasound or MRI, which detect anatomical features such as a mass, the Sentinel BreastScan uses infrared technology to identify physiological features of the breast tissue — areas of […]
New England Aesthetic Startups Attract Venture Capital
A number of aesthetic startups from Boston and its surrounding areas may be hitting the scene at precisely the right time. That’s according to the latest edition of “Innovation Economy,” a new Boston Globe column about entrepreneurship, which says that financially able baby boomers and a lack of interest among large pharmaceutical and biotech companies […]
BioForce Nanosciences Backed by NIH Grant
BioForce Nanosciences, a nanotech company based in Ames, IA, has received the second half of a $400,000 grant from the National Institutes of Health (NIH).
The funding will be used to develop and test BioForce’s Chip-on-a-Tip technology, a nanobiosensor capable of detecting protein biomarkers from just a few cells. It’s designed to provide fast analysis of […]
Plexus Biomedical Raises $2 Million
Plexus Biomedical, a small device company based in Oakland, TN, has raised $2 million from individual investors, according to an exclusive report by TechJournal South.
The company’s CEO, David Burton, was tight lipped about Plexus’ technology, but research by TechJournal on clinicaltrials.gov uncovered a study by Plexus Biomedical and the University of Tennessee Health Science Center […]
VC Industry Takes Up Reimbursement with Congress
The National Venture Capital Association (NVCA) is meeting with Congress today to make recommendations for more transparent and expedited reimbursement policies for new medical technologies.
The association will be talking with Congress’ House Medical Technology Caucus, about how inefficient reimbursement processes plagued by administrative barriers create an environment in which investors tend to back products with […]
Medivance Hopes D Financing Leads to Profitability
Medivance, a Louisville, CO, company that makes temperature-management devices, has completed a $23 million Series D financing. The money will be used to expand the market for the private company’s Arctic Sun Temperature Management System. Increased sales of the product, said CEO Robert Kline in a statement, will provide Medivance with “the means to […]
Trans1 Files for IPO
Trans1, a spinal-surgery device company based in Wilmington, NC, has filed to raise up to $80.5 million in an initial public offering of stock. The company, which hopes to be known as “TSON” on the Nasdaq exchange, did not reveal how many shares it would offer or how much it would charge.
Founded in 2000, Trans1 […]
